ClinicalTrials.gg
Active, not recruitingNCT02696603mPowerUpdated Jun 11, 2025

Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)

An interventional study of Participant self-assessment surveys and Phonation in Parkinson Disease, Neurodegenerative Diseases and Movement Disorders, sponsored by Sage Bionetworks. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-11.

Sponsored by Sage Bionetworks · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Mar 2015, registered Feb 2016).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20,000
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,650 studies in Parkinson Disease with a site in United States — 305 open to participants now, 387 under way, 7 of them phase 3. Parkinson Disease · United States.

Planned enrollment
3rd of 1,257
20,000 · median 36
Started
2015
with 65 others
No phase
586 of 1,650
147 open now
Primary completion
2018-02
later than 0 of 384 live
Registered
687th of 1,650
by date

Among the 1,650 studies in Parkinson Disease with a site in United States, this one is the 3rd largest by planned enrollment of the 1,257 interventional ones that give a count, is one of 66 that started in 2015, is one of 586 with no phase, reaches primary completion later than 0 of the 384 other live ones, and was the 687th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

305 of the 1,650 studies in Parkinson Disease with a site in United States are open now. Recruiting first, the newest first:

300 more — sign in →

All 305 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,650 studies in Parkinson Disease with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to understand variation in the symptoms of Parkinson disease. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Read the detailed description

Living with Parkinson disease means coping with symptoms that change every day. Yet these changes are not tracked frequently enough. Most people with Parkinson disease see a clinician only once or twice a year. This study measures changes in Parkinson disease symptoms in real time using an app. The app remotely monitors Parkinson disease symptoms using surveys and the sensors on mobile devices. This study may contribute to increasing our understanding of the variability in Parkinson disease symptoms. This knowledge could be used to improve quality of life for people living with Parkinson disease.

03

Conditions studied

  • Parkinson Disease
  • Neurodegenerative Diseases
  • Movement Disorders
  • Central Nervous System Diseases
  • Brain Diseases
  • Basal Ganglia Diseases
  • Parkinsonian Disorders

Keywords

  • Health app research
  • mHealth research
  • Mobile health research
  • Mobile application health research
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 years
  2. Have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later)
  3. Be able to read and understand an official language of the country of participation
  4. Be able to provide (i.e., pass assessment quiz)
  5. Be willing to follow study procedures

Exclusion criteria

Exclusion Criteria:

  1. Age 17 years or younger
  2. Not a resident of the of a country where the app is approved for use
  3. Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later)
  4. Not be able to read and understand an official language of the country of participation
  5. Not be able to give
  6. Not be willing to follow study procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20,000 participants (estimated)

Study arms

  • Experimental
    Participants with Parkinson disease

    People who report a diagnosis of Parkinson disease. Participants are invited via the Parkinson mPower mobile application to complete the following behavioral interventions: Participant self-assessment surveys, Phonation, Gait and balance, Memory, Dexterity, and Participant open-response writing.

    Behavioral: Participant self-assessment surveys · Behavioral: Phonation · Behavioral: Gait and balance · Behavioral: Memory · Behavioral: Dexterity · Behavioral: Participant open-response writing · Other: Parkinson mPower mobile application

  • Experimental
    Participants without Parkinson disease

    People who do not report a diagnosis of Parkinson disease. Participants are invited via the Parkinson mPower mobile application to complete the following behavioral interventions: Participant self-assessment surveys, Phonation, Gait and balance, Memory, Dexterity, and Participant open-response writing.

    Behavioral: Participant self-assessment surveys · Behavioral: Phonation · Behavioral: Gait and balance · Behavioral: Memory · Behavioral: Dexterity · Behavioral: Participant open-response writing · Other: Parkinson mPower mobile application

Interventions

  • BehavioralParticipant self-assessment surveys

    At enrollment, participants are asked to complete a baseline health history and a participant-reported symptom inventory. Thereafter, participants are asked to respond to commonly used questions that assess Parkinson Disease symptoms and quality of life at regular intervals.

  • BehavioralPhonation

    Participants are asked to record themselves saying "Aaah" for 10 seconds using the iPhone microphone. This activity is designed to assess vocal features, including vocal tremor. The investigators extract features from the digital audio signals of these sustained phonations. The investigators apply feature selection and classifier algorithms and analyze these phonations using methods similar to those employed in the Parkinson Voice Initiative.

  • BehavioralGait and balance

    Participants are asked to walk back and forth for 30 seconds and then stand still for 30 seconds. Gait and balance are measured by gyroscope and accelerometer sensors. The investigators examine step-dependent and sequence-dependent features from these sensors. The investigators apply feature selection and classifier algorithms to analyze these data.

  • BehavioralMemory

    Participants are asked to complete a visuospatial short-term memory game related to the Corsi block tapping test \[Corsi, P.M. (1972)\] as adapted by Kate Possin, PhD of the University of California San Francisco Memory and Aging Center (personal communication, 2015). In this activity, participants are presented with a grid of objects that change color in a set pattern. Participants are then asked to tap the objects in that same pattern. The investigators assess the sequence length completed.

  • BehavioralDexterity

    Participants are asked to tap on the phone screen with alternating fingers. This test can be done with either or both hands. The investigators record the rhythm, speed, and location of these taps using the touch sensors of the iPhone screen. The investigators assess participant dexterity through a combination of steadiness, speed, and tap precision.

  • BehavioralParticipant open-response writing

    Qualitative participant feedback is used to assess participant engagement with, understanding of, and acceptance of app-based research.

  • OtherParkinson mPower mobile application

    Participants complete all described behavioral interventions via a dedicated iPhone app, Parkinson mPower.

06

What researchers measure

Primary outcomes

  1. Results of participant self-assessment surveys

    Results of participant self-assessment surveys will be analyzed using descriptive statistics. These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

  2. Digital audio signals of sustained phonation from phonation intervention

    The investigators extract features from the digital audio signals of sustained phonations. The investigators apply feature selection and classifier algorithms and analyze these phonations using methods similar to those employed in the Parkinson Voice Initiative (http://www.parkinsonsvoice.org/science.php). These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

  3. Gyroscope and accelerometer sensor measurements from gait and balance intervention

    The investigators examine step-dependent and sequence-dependent features from gyroscope and accelerometer sensors. The investigators apply feature selection and classifier algorithms to analyze these data. These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

  4. Sequence length from memory intervention

    The investigators assess the sequence length completed in the Memory intervention. These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

  5. iPhone screen touch sensor data on rhythm, speed, and location of taps from dexterity intervention

    The investigators assess participant dexterity through a combination of steadiness, speed, and tap precision. These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

  6. App usage data for assessment of participant engagement

    App usage data is used to gauge participant engagement throughout the study period. These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

  7. Qualitative analysis of participant open-response and app usage data to assess participant acceptance of app-based research

    App usage data and qualitative participant feedback are used to assess participant understanding and acceptance of app-based research. These results may also be compared with other intervention results.

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 site
  • Sage Bionetworks
    Seattle, Washington 98109, United States
08

References and documents

Publications

  • Corsi, P.M. (1972). Human memory and the medial temporal region of the brain (Ph.D.). McGill University.
  • Kessels RP, van Zandvoort MJ, Postma A, Kappelle LJ, de Haan EH. The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol. 2000;7(4):252-8. doi: 10.1207/S15324826AN0704_8. PubMed 11296689 ↗
  • Klucken J, Barth J, Kugler P, Schlachetzki J, Henze T, Marxreiter F, Kohl Z, Steidl R, Hornegger J, Eskofier B, Winkler J. Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease. PLoS One. 2013;8(2):e56956. doi: 10.1371/journal.pone.0056956. Epub 2013 Feb 19. PubMed 23431395 ↗
  • Chaibub Neto E, Bot BM, Perumal T, Omberg L, Guinney J, Kellen M, Klein A, Friend SH, Trister AD. PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA. Pac Symp Biocomput. 2016;21:273-84. PubMed 26776193 ↗

Individual participant data

Plan to share: Yes — Coded data authorized for sharing by participants will be made available for research purposes via Synapse, Sage Bionetworks' analysis platform. Coded data is study data that does not include participants names or other directly identifying information.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2015 to primary completion in Feb 2018, 35 months.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 35 months is above that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2016
First posted
Mar 2, 2016
StartActual
Mar 2015
Primary completionActual
Feb 28, 2018
CompletionEst.
Dec 31, 2025
Last update
Jun 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02696603
Lead sponsor
Sage Bionetworks
Collaborators
Robert Wood Johnson Foundation
Responsible party
Sponsor
First posted
Mar 2, 2016
Start date
Mar 2015
Primary completion
Feb 28, 2018
Completion
Dec 31, 2025 (estimated)
Last update
Jun 11, 2025

Study contacts

Solly Sieberts, PhD
principal investigator · Sage Bionetworks

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion